Symptoms and sleep patterns during inpatient treatment of methamphetamine withdrawal: A comparison of mirtazapine and modafinil with treatment as usual
The safety and tolerability of modafinil (400 mg/day, n = 14) and mirtazapine (60 mg/day, n = 13) in inpatient methamphetamine withdrawal treatment were compared to a historical comparison group receiving treatment as usual (pericyazine, 2.5-10 mg/day, n = 22). Modafinil and mirtazapine were well to...
Saved in:
Main Authors: | Catherine McGregor, Manit Srisurapanont, Amanda Mitchell, Wendy Wickes, Jason M. White |
---|---|
Format: | Journal |
Published: |
2018
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=51249102926&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/60590 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Symptoms and sleep patterns during inpatient treatment of methamphetamine withdrawal: A comparison of mirtazapine and modafinil with treatment as usual
by: McGregor C., et al.
Published: (2014) -
The nature, time course and severity of methamphetamine withdrawal
by: Catherine McGregor, et al.
Published: (2018) -
The nature, time course and severity of methamphetamine withdrawal
by: McGregor C., et al.
Published: (2014) -
Treatment for amphetamine withdrawal.
by: Srisurapanont M., et al.
Published: (2014) -
Methamphetamine psychosis in Australia, Philippines, and Thailand: Recommendations for acute care and clinical inpatient management
by: Robert Ali, et al.
Published: (2018)